Topics
Technologies
Photo by BoliviaInteligente on Unsplash
Following an annual CGS tradition, we present a selection of our favorite Biopolitical Times posts...
Image by Mohamed Hassan from Pixabay
It is hard to make predictions, especially about the future, as Yogi Berra, Niels...
In-vitro fertilisation (IVF) as assisted reproductive technology (ART) has been in vogue for quite a few decades now. While IVF...
In the days after Daphna Cardinale delivered her second child, she experienced a rare sense of calm and wonder. The...
Policies
Photo by BoliviaInteligente on Unsplash
Following an annual CGS tradition, we present a selection of our favorite Biopolitical Times posts...
Lucy Landman was born with a very rare genetic disorder that causes severe intellectual disability, weak muscles and seizures...
(Bloomberg) — A woman in Hong Kong had to travel to two different countries to attempt conceiving a baby on...
The Centers for Medicare & Medicaid Services said on Wednesday it had entered into agreements with Vertex Pharmaceuticals (VRTX.O), opens...
Society
Photo by BoliviaInteligente on Unsplash
Following an annual CGS tradition, we present a selection of our favorite Biopolitical Times posts...
FOR YEARS NOW, aspiring parents have been designing their children. Screening embryos for disease-causing genes during IVF, selecting their future baby’s...
"Richard Lynn" by Matt Gibson licensed under CC by SA 3.0
A leading academic publisher is reviewing...
It was somewhere between the third and fourth child that Catherine Pakaluk had a revelation.
“There was this sense that...
Perspectives
Photo by BoliviaInteligente on Unsplash
Following an annual CGS tradition, we present a selection of our favorite Biopolitical Times posts...
As more people access fertility services in their journeys to becoming parents, Toronto Metropolitan University professor Katie Hammond says the...
A single cell.
A global business worth billions.
A trade that can bring rewards—or human costs that cannot be measured...
23andMe, a major company providing direct-to-consumer genetic testing, has been struggling financially since late 2023. In September 2024, the company’s...